Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives $57.38 Consensus Price Target from Brokerages
Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) has earned an average rating of “Buy” from the nine ratings firms that are covering the company, MarketBeat Ratings reports. Nine equities research analysts have rated the stock with a buy rating. The average 1 year price objective among brokerages that have issued ratings on the stock […]
Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) has earned an average rating of “Buy” from the nine ratings firms that are covering the company, MarketBeat Ratings reports. Nine equities research analysts have rated the stock with a buy rating. The average 1 year price objective among brokerages that have issued ratings on the stock […]
